close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Steroids Worsen Chickenpox

October 31, 2005

Children who get chickenpox while on steroid therapy may be under a life-threatening risk, according to a study published in the October edition of Pediatrics and reported by Time magazine (online edition) on 20 October 2005.

Steroids are commonly used to treat childhood leukemia and to treat severe asthma. But steroids suppress the immune system, permitting more severe infection by the varicella virus, a herpes virus that causes chickenpox and, in adults, shingles.

Chickenpox derives its name from the appearance of chickpea-like red bumps that appear on the skin. Chickenpox affects about four million people in the US annually; about 100 die of the disease.

Retrospective Study

Researchers Garick Hill et al. conducted a retrospective review of data on 697 patients who had acute lymphoblastic leukemia (ALL) and a history of varicella infection. Individual cases of varicella were graded 1 to 5 based on severity.

Of the 110 (~16%) of patients who contracted chickenpox, 54 had infection rated as 'severe' (i.e., graded 3-5), characterized by requiring hospitalization to being life-threatening. Two children died during the study.

Disease severity was greater in children who contracted chickenpox within a three-week period after steroid treatment: 70% of patients in this group developed severe chickenpox, compared with only 44% who developed chickenpox after that period.

The authors noted that, while the current study concerns only children with ALL, the study's results may apply to other cases where patients are on steroid therapy. They also noted a trend towards greater severity of infection in older patients, as has been previously documented.

Many parents view chickenpox as a one-time inconvenience, but prefer to have their children exposed to varicella early, because of the risk of serious infection associated with contracting chickenpox as an adult.

A chickenpox vaccine with 85% efficacy has been licensed for public use since 1995 for healthy children. However, because the vaccine is a live virus, children with compromised immune systems (such as ALL patients) might have a severe reaction to it.

Sources:
Steroids Intensify Chickenpox, The Daily Rx/Time magazine online edition, 20 October 2005.
Recent Steroid Therapy Increases Severity of Varicella Infections in Children With Acute Lymphoblastic Leukemia, Pediatrics, volume 116(4), pages e525-e529, October 2005.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...